Company intelligence / Profile preview
HERMES ARZNEIMITTEL
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
HERMES ARZNEIMITTEL is a German pharmaceutical and consumer health company focused on self-medication and over-the-counter healthcare products. The company develops, manufactures, and markets a broad portfolio of branded OTC medicines, dietary supplements, dermopharmaceutical products, and selected medical devices, with flagship brands including Biolectra, doc, Aspecton, algovir, Betaisodona, and ANTI BRUMM. It is part of the privately held HERMES Group and operates primarily from Pullach, Germany, with additional presence in Austria and export partnerships across multiple international markets. The business is commercial-stage rather than pipeline-driven, with strong emphasis on brand management, pharmacy channel distribution, and everyday health categories such as musculoskeletal health, respiratory care, wound care, and prevention. HERMES ARZNEIMITTEL is best characterized as an established OTC pharma company rather than a biotech innovator.
- Therapeutic areas
- HematologyImmunologyOtherEndocrinologyCardiovascularNeurologyDermatologyInfectious DiseasesRheumatologyPulmonology
- Modalities
- Small moleculeBiologicDevicePhytopharmaceutical
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on HERMES ARZNEIMITTEL.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HERMES ARZNEIMITTEL.